Brought to you by 
Aurobindo acquires Apotex's generic businesses for $87mm
17 Jul 2018
Executive Summary
Canadian drug maker Apotex Inc. agreed to sell off its generic businesses in Poland, Czech Republic, the Netherlands, Spain, and Belgium to India's third largest drug company, Aurobindo Pharma Ltd.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Aurobindo acquires Apotex's generic businesses for $87mm
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice